Earnings Feed
Start Free
Home/Filings/4/0001179110-21-004092
4//SEC Filing

TULLMAN GLEN 4

Accession 0001179110-21-004092

CIK 0001477449other
View on SEC.govCompany Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 3:03 PM ET

Size

20.5 KB

Accession

0001179110-21-004092

Insider Transaction Report

Form 4
Period: 2021-04-01
Teladoc Health, Inc.TDOC
TULLMAN GLEN
Director
Transactions
  • Sale

    Common Stock

    2021-04-01$183.78/sh−45,089$8,286,628→ 500,419 total
  • Exercise/Conversion

    Common Stock

    2021-04-01$5.26/sh+329,863$1,735,079→ 605,656 total
  • Sale

    Common Stock

    2021-04-01$188.45/sh−17,477$3,293,467→ 275,793 total
  • Sale

    Common Stock

    2021-04-01$184.68/sh−44,825$8,278,375→ 455,594 total
  • Sale

    Common Stock

    2021-04-01$187.85/sh−98,588$18,520,071→ 293,270 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-04-01−329,863→ 0 total
    Exercise: $5.26Exp: 2021-04-30→ Common Stock (329,863 underlying)
  • Sale

    Common Stock

    2021-04-01$186.92/sh−38,977$7,285,760→ 391,858 total
  • Sale

    Common Stock

    2021-04-01$182.78/sh−60,148$10,993,912→ 545,508 total
  • Sale

    Common Stock

    2021-04-01$185.80/sh−24,759$4,600,128→ 430,835 total
Holdings

  • Common Stock

    (indirect: See footnote)
    21,233

  • Common Stock

    (indirect: See footnote)
    1,812
Footnotes (11)
  • [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on December 14, 2020.
  • [F10]The shares are held of record by 7wire Management I, LLC. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Management I, LLC. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  • [F11]The option vested in full on October 30, 2020.
  • [F2]Represents the weighted average price of transactions ranging from $182.29 to $183.28. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 8 to this Form 4.
  • [F3]Represents the weighted average price of transactions ranging from $183.29 to $184.28.
  • [F4]Represents the weighted average price of transactions ranging from $184.29 to $185.28.
  • [F5]Represents the weighted average price of transactions ranging from $185.30 to $186.28.
  • [F6]Represents the weighted average price of transactions ranging from $186.30 to $187.29.
  • [F7]Represents the weighted average price of transactions ranging from $187.30 to $188.29.
  • [F8]Represents the weighted average price of transactions ranging from $188.295 to $189.00.
  • [F9]The shares are held of record by 7wire Ventures Fund, L.P. The reporting person serves as a Manager of 7wire Management, LLC, the Manager of 7wire Ventures Fund, L.P. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

Teladoc Health, Inc.

CIK 0001477449

→
Entity typeother

Related Parties

1
  • filerCIK 0001213349

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 3:03 PM ET
Size
20.5 KB
View on SEC.gov